ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK
2.2200
24-January-25 16:45:00
15 minutes delayed
Stocks
-0.0800
-3.48%
Today's range
2.2088 - 2.4100
ISIN
N/A
Source
NASDAQ
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2024 17:30:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Mar 2024 18:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
28 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference
13 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2024 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
25 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jan 2024 16:49:03 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 17:39:15 By Nasdaq GlobeNewswire
-
09 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
06 Nov 2023 07:18:31 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2023 16:52:14 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Oct 2023 16:27:36 By Nasdaq GlobeNewswire
-
06 Sep 2023 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2023 16:37:58 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
09 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2023 16:28:31 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy Officer
01 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock
15 Jun 2023 06:01:28 By Nasdaq GlobeNewswire